ArticleBioengineered2022

Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway.

Fagen Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.